AwardedSpainGoodsDynamic purchasing system€1,887,515
Adjudicación del Contrato Específico del Medicamento BIMEKIZUMAB, derivado del Sistema Dinámico de Adquisición del Suministro de Medicamentos Exclusivos, para el Consorci Sanitari Integral
- Published
- Published 5 June 2026
Overview
The Consorci Sanitari Integral has awarded a contract for the supply of the pharmaceutical medicine Bimekizumab, valued at €1,887,514.60, to UCB PHARMA, S.A. as of 29 May 2026. The procurement was conducted through a dynamic acquisition system for exclusive medicines and is now complete.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €1,887,515
- Procedure
- Selective
- Contract type
- Dynamic purchasing system
- Published
- 5 June 2026
Pharmaceutical products
Award outcome
- Awarded value
- €1,887,515
- Award date
- 29 May 2026
- Contract period
- 29 May 2026 → 24 May 2027
- UCB PHARMA, S.A.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
5 June 2026
Contracting authority
Consorci Sanitari Integral
Procuring entityL’Hospitalet de Llobregat, Spain
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.